Literature DB >> 33459778

Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study.

Paul Kurdyak1,2,3, Emilie Mallia1,2, Claire de Oliveira1,2, Andre F Carvalho1, Nicole Kozloff1,2, Juveria Zaheer1, Wanda M Tempelaar1, Kelly K Anderson2,3,4, Christoph U Correll5,6,7, Aristotle N Voineskos1,2.   

Abstract

There is emerging evidence of high mortality rates after the first diagnosis of psychotic disorder. The objective of this study was to estimate the standardized mortality ratio (SMR) in a population-based cohort of individuals with a first diagnosis of schizophrenia-spectrum psychotic disorder (SSD). The cohort included a population-based sample of individuals with a first diagnosis of SSD based on the first diagnosis occurring during hospitalization or in an outpatient setting between 2007 and 2010 in Ontario, Canada. All patients were followed for 5 years after the first diagnosis. The primary outcome was SMR, including all-cause, suicide-related, accidental, and other causes. Between 2007 and 2010, there were 2382 patients in the hospitalization cohort and 11 003 patients in the outpatient cohort. Over the 5-year observation period, 97 (4.1%) of the hospitalization cohort and 292 (2.7%) of the outpatient cohort died, resulting in an SMR of 13.6 and 9.1, respectively. In both cohorts, suicide was the most common cause of death. Approximately 1 in 25 patients with a first diagnosis of SSD during hospitalization, and 1 in 40 patients with a first diagnosis of SSD in an outpatient setting, died within 5 years of first diagnosis in Ontario, Canada. This mortality rate is between 9 and 13 times higher than would be expected in the age-matched general population. Based on these data, timely access to services should be a public health priority to reduce mortality following a first diagnosis of an SSD.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  first episode; mortality; schizophrenia

Mesh:

Year:  2021        PMID: 33459778      PMCID: PMC8084423          DOI: 10.1093/schbul/sbaa180

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  26 in total

1.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

Review 2.  Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt: a meta-analysis.

Authors:  Masatoshi Inagaki; Yoshitaka Kawashima; Chiaki Kawanishi; Naohiro Yonemoto; Tatsuya Sugimoto; Taku Furuno; Katsumi Ikeshita; Nobuaki Eto; Hirokazu Tachikawa; Yohko Shiraishi; Mitsuhiko Yamada
Journal:  J Affect Disord       Date:  2014-12-30       Impact factor: 4.839

3.  Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia.

Authors:  Heidi Taipale; Ellenor Mittendorfer-Rutz; Kristina Alexanderson; Maila Majak; Juha Mehtälä; Fabian Hoti; Erik Jedenius; Dana Enkusson; Amy Leval; Jan Sermon; Antti Tanskanen; Jari Tiihonen
Journal:  Schizophr Res       Date:  2017-12-21       Impact factor: 4.939

4.  Effectiveness of Early Psychosis Intervention: Comparison of Service Users and Nonusers in Population-Based Health Administrative Data.

Authors:  Kelly K Anderson; Ross Norman; Arlene MacDougall; Jordan Edwards; Lena Palaniyappan; Cindy Lau; Paul Kurdyak
Journal:  Am J Psychiatry       Date:  2018-03-02       Impact factor: 18.112

5.  The iHOPE-20 study: mortality in first episode psychosis-a 20-year follow-up of the Dublin first episode cohort.

Authors:  Roisin Doyle; Donal O'Keeffe; Ailish Hannigan; Anthony Kinsella; Caragh Behan; Aine Kelly; Ann Sheridan; Kevin Madigan; Elizabeth Lawlor; Mary Clarke
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

6.  Diagnostic stability of first-episode psychosis. Comparison of ICD-10 and DSM-III-R systems.

Authors:  S Amin; S P Singh; J Brewin; P B Jones; I Medley; G Harrison
Journal:  Br J Psychiatry       Date:  1999-12       Impact factor: 9.319

Review 7.  Suicidal behavior and mortality in first-episode psychosis.

Authors:  Merete Nordentoft; Trine Madsen; Izabela Fedyszyn
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

8.  Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years.

Authors:  Jentien M Vermeulen; Geeske van Rooijen; Marita P J van de Kerkhof; Arjen L Sutterland; Christoph U Correll; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

9.  Premature Mortality Among Adults With Schizophrenia in the United States.

Authors:  Mark Olfson; Tobias Gerhard; Cecilia Huang; Stephen Crystal; T Scott Stroup
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

10.  Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.

Authors:  Lisa B Dixon; Howard H Goldman; Vinod H Srihari; John M Kane
Journal:  Annu Rev Clin Psychol       Date:  2018-01-12       Impact factor: 18.561

View more
  2 in total

1.  Low physical activity is associated with two hypokinetic motor abnormalities in psychosis.

Authors:  Sebastian Walther; Irena Vladimirova; Danai Alexaki; Lea Schäppi; Kathrine S F Damme; Vijay A Mittal; Stewart A Shankman; Katharina Stegmayer
Journal:  J Psychiatr Res       Date:  2021-11-08       Impact factor: 4.791

2.  Risk Factors for Deliberate Self-harm and Suicide Among Adolescents and Young Adults With First-Episode Psychosis.

Authors:  Aubrey M Moe; Elyse Llamocca; Heather M Wastler; Danielle L Steelesmith; Guy Brock; Jeffrey A Bridge; Cynthia A Fontanella
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.